trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Genetically engineered plants can be used to produce antibodies, which are sometimes referred to as plantibodies.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that genetically engineered plants can be used to produce antibodies, which are sometimes referred to as plantibodies?

Yes. Genetically engineered plants serve as a viable production platform for therapeutic proteins, with antibodies produced via this method widely known in the literature as plantibodies.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently support the premise that plant molecular farming utilizes genetically modified plants to express recombinant proteins, specifically identifying antibodies produced in this manner as plantibodies. No papers refute this established terminology and scientific application.

Evidence for · 4
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
2020
This review highlights plant molecular farming as a platform for producing biopharmaceuticals, including monoclonal antibodies.
Get citation
Shanmugaraj, B., Bulaon, C. J. I., & Phoolcharoen, W. (2020). Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production. doi.org. https://doi.org/10.3390/plants9070842

See more details
More for · 3
Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems
2024
The paper discusses the use of molecular farming in plant systems to produce recombinant molecular medicines such as recombinant antibodies.
Get citation
Bharathi, J. K., Suresh, P., Prakash, M., & Muneer, S. (2024). Exploring recent progress of molecular farming for therapeutic and recombinant molecules in plant systems. doi.org. https://doi.org/10.1016/j.heliyon.2024.e37634

Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals.
2023
The review notes that plants have successfully produced therapeutic proteins, including anti-Ebola monoclonal antibodies.
Get citation
G, Z., AAA, A., K, T., G, M., MM, T., I, M., & GP, L. (2023). Green Biologics: Harnessing the Power of Plants to Produce Pharmaceuticals.. doi.org. https://doi.org/10.3390/ijms242417575

Plant-related quality attributes affecting FcγRIIIa binding: affinity chromatography analysis of rituximab glycovariants from <i>Nicotiana benthamiana</i>.
2025
The study specifically investigates monoclonal antibodies produced in Nicotiana benthamiana plants, explicitly referred to as plantibodies.
Get citation
S, T., A, T., C, M., F, R., I, S., E, C., V, P., C, P., M, D., & C, T. (2025). Plant-related quality attributes affecting FcγRIIIa binding: affinity chromatography analysis of rituximab glycovariants from <i>Nicotiana benthamiana</i>.. doi.org. https://doi.org/10.3389/fpls.2025.1607403

What does the evidence say?

The retrieved papers consistently support the premise that plant molecular farming utilizes genetically modified plants to express recombinant proteins, specifically identifying antibodies produced in this manner as plantibodies. No papers refute this established terminology and scientific application.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work